Mustang Bio Stock (NASDAQ:MBIO), Quotes and News Summary

Q: How do I buy Mustang Bio (MBIO) stock?

You can purchase shares of Mustang Bio (NASDAQ: MBIO) through any online brokerage. View our list of the best stock brokerages.

Q: Who are Mustang Bio's (MBIO) competitors?

Other companies in Mustang Bio’s space includes: Alzamend Neuro (NASDAQ:ALZN) , Dermata Therapeutics (NASDAQ:DRMA) , Quoin Pharmaceuticals (NASDAQ:QNRX) , Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Geovax Labs (NASDAQ:GOVX) .

Q: What is the target price for Mustang Bio (MBIO) stock?

The latest price target for Mustang Bio (NASDAQ: MBIO) was reported by Cantor Fitzgerald on Thursday, August 24, 2023. The analyst firm set a price target for 18.00 expecting MBIO to rise to within 12 months (a possible 6890.29% upside). 7 analyst firms have reported ratings in the last year.

Q: Current Stock Price for Mustang Bio (MBIO)?

The stock price for Mustang Bio (NASDAQ: MBIO) is $0.2575 last updated May 10, 2024 at 7:26 PM EDT.

Q: Does Mustang Bio (MBIO) pay a dividend?

There are no upcoming dividends for Mustang Bio.

Q: When is Mustang Bio (NASDAQ:MBIO) reporting earnings?

Mustang Bio’s Q1 earnings are confirmed for Tuesday, May 21, 2024.

Q: Is Mustang Bio (MBIO) going to split?

There is no upcoming split for Mustang Bio.

Q: What sector and industry does Mustang Bio (MBIO) operate in?

Mustang Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Mustang Bio Stock (NASDAQ: MBIO) stock price, news, charts, stock research, profile.

Open	$0.268
Close	$0.260
Volume / Avg.	74.559K / 243.519K
Day Range	0.251 - 0.280
52 Wk Range	0.220 - 8.170
Market Cap	$3.223M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	1.42%
Days to Cover	1

Recent News

Why Rush Street Interactive Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket

Shares of Rush Street Interactive, Inc. (NYSE: RSI) rose sharply in today’s pre-market trading as the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for 2024.

Avi Kapoor

Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers

Lisa Levin

Why Mustang Bio's Stock Is Trading Higher Today

Mustang Bio Inc (NASDAQ: MBIO) announced that final data from the follicular lymphoma cohort of the single-institution Phase 1/2 clinical trial of MB-106 demonstrate treatment with the CD20-targeted, autologous CAR T-cell therapy resulted in high overall response (ORR) and complete response (CR) <

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Mustang Bio (MBIO) stock?

You can purchase shares of Mustang Bio (NASDAQ: MBIO) through any online brokerage.

View our list of the best stock brokerages.

Who are Mustang Bio's (MBIO) competitors?

Other companies in Mustang Bio’s space includes: Alzamend Neuro (NASDAQ:ALZN), Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Geovax Labs (NASDAQ:GOVX).

What is the target price for Mustang Bio (MBIO) stock?